← Eichor
Study identifier: NCT06267508 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment

Condition: Vertical Human Immunodeficiency Virus Transmission · HIV Infection Pediatric · Infant Death  ·  Sponsor: Michael Hoelscher

PhaseN/A
Planned participants6000
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to improve HIV healthcare services for mothers living with HIV and their newborns in Tanzania and Mozambique. The main questions it aims to answer are: 1) does enhancing screening with maternal HIV viral load monitoring at delivery identify more mother-child pairs at high-risk for HIV vertical transmission? and 2) are high-risk infants linked to appropriate prevention and care? The study will expand access to HIV testing services to more rural settings using a hub-and-spoke referral system.

This description comes directly from the study's public registry record.

Talk to the study team

Arne Kroidl, MD  ·  +49-89-4400  ·  Arne.Kroidl@med.uni-muenchen.de

Amy Heilman

Always discuss trial participation with your own doctor first.

Locations (2)

Centro de Investigacao Operacional de Beira (CIOB), Instituto Nacional de Saúde (INS), Ministério da Saúde,Beira, MozambiqueRecruiting
National Institute for Medical Research (NIMR)Mbeya, Mbeya, TanzaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06267508